Performant Healthcare, Inc. (PHLT)
NASDAQ: PHLT · Real-Time Price · USD
4.210
-0.100 (-2.32%)
Jul 11, 2025, 9:42 AM - Market open

Performant Healthcare Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Performant Healthcare stock has a target of 8, which predicts a 90.02% increase from the current stock price of 4.21.

Price Target: $8 (+90.02%)
Analyst Consensus: Buy
Target Low Average Median High
Price $8.00 $8.00 $8.00 $8.00
Change +90.02% +90.02% +90.02% +90.02%

Analyst Ratings

According to 1 stock analyst, the rating for Performant Healthcare is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '25
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JMP Securities
JMP Securities
Buy
Initiates
$8
Buy Initiates $8 +90.02% Jul 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
136.54M
from 122.98M
Increased by 11.03%
Revenue Next Year
151.88M
from 136.54M
Increased by 11.23%
EPS This Year
0.02
from -0.13
EPS Next Year
0.12
from 0.02
Increased by 666.67%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
155.94M124.39M109.18M113.74M122.98M136.54M151.88M
Revenue Growth
3.66% -20.23% -12.23% 4.18% 8.12% 11.03% 11.23%
EPS
-0.26-0.17-0.09-0.10-0.130.020.12
EPS Growth
- - - - - - 666.67%
Forward PE
-----275.1635.89
No. Analysts
-----55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High 140.9M 158.7M
Avg 136.5M 151.9M
Low 130.7M 143.7M

Revenue Growth

Revenue Growth 20252026
High
14.6%
16.2%
Avg
11.0%
11.2%
Low
6.3%
5.2%

EPS Forecast

EPS 20252026
High 0.03 0.17
Avg 0.02 0.12
Low - 0.07

EPS Growth

EPS Growth 20252026
High -
998.0%
Avg -
666.7%
Low -
348.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.